argyrotsipi/train-dataset huggingface dataset:
Independent Medicines and Medical Devices Safety Review — House of Commons, 2020-07-09
Topic: Health
Nadine Vanessa Dorries (Conservative, Centre-right): My hon. Friend raises the important issue of informed consent, which has come very much to the fore recently, including how detailed consent needs to be and how much information people need to have. Of course we are working with those women and ensuring that they have every detail and every bit of information that they require before mesh is removed so that they know exactly what operation they are undergoing. That needs to be a template for moving forward. Informed consent needs to be what we move forward with in much more detail, so patients are fully aware of the risks and benefits of any surgical procedure they are undergoing.
Independent Medicines and Medical Devices Safety Review — House of Commons, 2020-07-09
Topic: Health
Nadine Vanessa Dorries (Conservative, Centre-right): The hon. Lady is absolutely right in everything she said, and I completely agree with her, 100%. My team of officials and I, from the very first day that I arrived in the Department, have been looking at a women’s agenda and at the way that in so many areas of healthcare there does appear to be an unintentional bias. I am not saying that it is intentional and I would not particularly use the word "misogyny", but there is an unintentional bias. It is proven by the amount of time it takes for women to have their voices heard and for their complaints to be taken seriously and yes, addressing that is absolutely a priority. The problems that women were subjected to and the prolonged pain they experienced simply because their voices were not being heard is something that we will have to address in our response. That bias against women must surely be obvious from the amount of inquiries that we are having about women-only issues, and I hope that highlighting that, bringing it here and not being afraid to ask for inquiries where we see that bias taking place, is like shining sunlight on it—to quote someone long before my time. It is only by opening up these issues, allowing a spotlight to be shone on them and not being afraid of what we find that we can go anywhere towards addressing this. We do it by establishing a blame-free culture, a bit like the airlines industry has in the HSSIB, where we look at incidents that have happened, do not blame anyone, and make sure clinicians, nurses and healthcare workers can reveal what has happened in an incident. By doing so, we can put the learnings in place to make sure that it does not happen again.
Independent Medicines and Medical Devices Safety Review — House of Commons, 2020-07-09
Topic: Health
Anne Marie Morris (Conservative, Centre-right): The report from Baroness Cumberlege is more than welcome. It demonstrates to me, and to many of us, that the key to getting this right is having the knowledge, because with knowledge we have power—the power to prevent something like this happening ever again. Only with that knowledge and that data can we ensure patient safety for the future, and safe innovation. In that regard, will the Minister consider going further than Cumberlege and the current medicine and medical devices legislation? We need a single database with all devices, not just those that are in vitro, and we do not need a web of connected databases; we need one. Also, we need this to be linked—we need information about devices and information about patient records connected, and those patient records must include primary and secondary care. I would like to see something that is truly integrated, internationally compatible and searchable, whether by universities, academics or the medical profession. I would like to see something that is state-of-the-art and internationally the best. To enable that, will the Minister create some form of protocol so that existing databases can in future be migrated into the master plan? At the moment, there is no plan for that. The concept is seen to be too difficult, but—
Independent Medicines and Medical Devices Safety Review — House of Commons, 2020-07-09
Topic: Health
Nadine Vanessa Dorries (Conservative, Centre-right): I will try to keep my answers shorter. The hon. Lady is absolutely right. The sodium valproate pregnancy prevention programme is running hand in hand with an information awareness programme. Many GPs are aware, but of course there is still a problem and it is something that we are addressing.
Independent Medicines and Medical Devices Safety Review — House of Commons, 2020-07-09
Topic: Health
Selaine Rachel Saxby (Conservative, Centre-right): My constituent Diane Surman’s daughter, Helen, was affected by the Primodos scandal, and I am delighted that their circumstances have finally been recognised for the injustice that they are. Will my hon. Friend assure me that the Government will do all they can to ensure that Bayer recognises its responsibilities, apologises and contributes towards the payments outlined in the report?
Independent Medicines and Medical Devices Safety Review — House of Commons, 2020-07-09
Topic: Health
Fiona Claire Bruce (Conservative, Centre-right): As vice-chair of the all-party group on valproate and other anti-epileptic drugs in pregnancy, I thank the Minister for her tone today. Does she agree that it is shocking that the Committee on Safety of Medicines as long ago as 1973—this is the predecessor of the MHRA—was clearly aware of the risks in pregnancy of the use of anticonvulsants? It said that they are liable to produce abnormalities. Over that period of time, 20,000 children could have been affected. There are families, such as those of Janet Williams and Emma Murphy, who have campaigned tirelessly—I pay tribute to them too on this issue—who now have to care for those children, potentially for their entire lives. Much more support is needed for those children from local authorities and health authorities. It has not been given until now as a result of the lack of recognition of the link between, and risks of, anticonvulsants in pregnancy and abnormalities. Will the Minister, when she meets us, focus on ensuring that that issue is taken forward so that more support can be provided?
Independent Medicines and Medical Devices Safety Review — House of Commons, 2020-07-09
Topic: Health
Nadine Vanessa Dorries (Conservative, Centre-right): The hon. Gentleman makes an interesting point about cancer trials. He may have heard the recent announcement that one of the Nightingale hospitals is to be used for processing cancer diagnoses. I believe that cancer treatments have started again, but I will come back to him with further information because this is not really in the scope of the report.
Independent Medicines and Medical Devices Safety Review — House of Commons, 2020-07-09
Topic: Health
Nadine Vanessa Dorries (Conservative, Centre-right): As I have just said, this is a two-and-a-half-year report: it is complex. It is a deep dive into issues relating to Primodos, sodium valproate and vaginal mesh. There is absolutely no way that I could come to the Dispatch Box today and do what my hon. Friend asks. We need to evaluate the report properly to do it justice—to do those brave women who came forward justice. As I say, we will return to the House with our recommendations and an evaluation of the reportj in full.
Independent Medicines and Medical Devices Safety Review — House of Commons, 2020-07-09
Topic: Health
Nadine Vanessa Dorries (Conservative, Centre-right): Apologies, but I am not sure what the hon. Member means in terms of patient safety in the past. All I can say is that patient safety is an absolute priority. My ministerial titled changed recently to Minister for Patient Safety, Mental Health and Suicide Prevention—patient safety is the first consideration in my title. I am the Minister of State for Patient Safety. That is a demonstration of the Department’s absolute commitment to patient safety going forward. It is a high priority in the Department of Health and Social Care. Everything we do in terms of health—from HSSIB and the CQC to NHS Improvement—and a number of measures that we have put in place in recent years demonstrates that commitment to patient safety. We want to make the NHS the safest healthcare system in the world. We continue to strive to achieve that.
Independent Medicines and Medical Devices Safety Review — House of Commons, 2020-07-09
Topic: Health
Kieran John Mullan (Conservative, Centre-right): I welcome the report and its wide-ranging recommendations, particularly those focused on a medical-devices registry and the need to improve our post-market surveillance of drugs and treatments in this country. However, I urge caution in respect of the risk of creating new posts and bureaucracy when we already have an extensive number of organisations—including the CQC, the ombudsman and Healthwatch—and hospitals themselves have a responsibility to listen to complainants, whatever the cause of their complaint might be. In my time at the Patients Association, we ran a survey of complainants across a number of hospitals to compare and pick up those hospitals that were not as good at listening as others. Does the Minister agree that, if all healthcare providers had to survey their complainants and we could compare how well providers were listening to them, we might see improvement on the frontline for patients, in respect of all different causes of complaint?
Independent Medicines and Medical Devices Safety Review — House of Commons, 2020-07-09
Topic: Health
Nadine Vanessa Dorries (Conservative, Centre-right): My hon. Friend makes a really important point. It is a recurring theme—over and over again—that when patients complain, the first point of complaint is to the trust where they were treated, but that is often where the logjam is. A patient-safety campaigner told me recently that it was seven years before the chief executive of a trust would even acknowledge his complaint or meet him. That is where we see the logjam happening. I will take away my hon. Friend’s point and consider it, because it is a very important one.
Independent Medicines and Medical Devices Safety Review — House of Commons, 2020-07-09
Topic: Health
Robert Peter Moore (Conservative, Centre-right): I welcome the statement and the report. My thoughts are with those individuals and families whose lives have been turned upside down by these issues. Will my hon. Friend work with the Medicines and Healthcare Products Regulatory Agency to ensure that patient safety is central to its work?
Independent Medicines and Medical Devices Safety Review — House of Commons, 2020-07-09
Topic: Health
Nadine Vanessa Dorries (Conservative, Centre-right): Absolutely. The MHRA itself is undergoing a culture change and an operational change and is itself looking into how it responds to patients and the way it considers patient safety as a priority. I am the Minister of State for Patient Safety. Making patient safety has to be one of our No. 1 criteria in the NHS. People who come into the NHS—who come into hospitals—have an absolute right to be confident and safe. All organisations in the healthcare structure need to do the same in that respect.
Proceedings during the Pandemic and Hybrid Scrutiny Proceedings — House of Commons, 2020-04-21
Topic: Health
Charles Ashley Rupert Walker (Conservative, Centre-right): Does the right hon. Gentleman agree that perhaps the usual order of departmental questions should be changed, so that we could get more chances to ask questions of the Treasury and the Department of Health and Social Care—the two Departments absolutely in the frontline of this crisis?
Covid-19: Developing Countries — House of Commons, 2020-04-29
Topic: Health
Anne-Marie Belinda Trevelyan (Conservative, Centre-right): I would first like to put on record my congratulations and that of all in the House on the safe arrival of the Prime Minister and Carrie Symonds’s son this morning With permission, Mr Speaker, I would like to update the House with the following announcement. The coronavirus pandemic shows the vital role that vaccines play in protecting us against disease. The UK is today committing new support to Gavi, the Vaccine Alliance. The UK’s pledge of the equivalent of £330 million a year for the next five years continues our leadership and commitment to global health security. The UK’s pledge will help to ensure the delivery of life-saving vaccinations in 68 countries, saving lives and strengthening health systems. It will therefore help to protect the UK and our NHS from future waves of coronavirus. I look forward to the UK-hosted Vaccine Alliance summit on 4 June, which will help to raise all the funds that Gavi needs to vaccinate 300 million children and save up to 8 million lives.
Covid-19: Developing Countries — House of Commons, 2020-04-29
Topic: Health
Anne-Marie Belinda Trevelyan (Conservative, Centre-right): The UK has confidence in the WHO and the work that it is doing globally to bring together every country to do the best they can to look after their communities and citizens. The WHO is co-ordinating PPE for all those countries, and we are supporting it by putting funding into the central pot, so that it can ensure that the countries that are most in need will have the PPE that they require.
Covid-19: Aid Programmes — House of Commons, 2020-04-29
Topic: Health
Anne-Marie Belinda Trevelyan (Conservative, Centre-right): Our response to covid-19, including on vaccines, treatments and testing, is a great example of joint working between DFID and the FCO, as well as with Department of Health and Social Care and Department for Business, Energy and Industrial Strategy experts. We are able to combine our world-class diplomatic network with DFID’s global leadership on development. We are proud of the UK’s close partnership with the Bill and Melinda Gates Foundation, including on the Wellcome therapeutics accelerator initiative, to which we committed up to £40 million with the aim of bringing 100 million courses of covid-19 treatment to those who will need it the most in 2020.
Covid-19: Research — House of Commons, 2020-04-29
Topic: Health
Wendy Morton (Conservative, Centre-right): Science can help us to deal with this crisis. To date, the UK has committed more than £330 million to innovative research and development of vaccines, rapid diagnostics and promising therapeutics for the coronavirus. The UK is the world’s top donor to CEPI, which is helping to produce a vaccine, including at Oxford and Imperial. We are also funding innovative research on virus tests and antibody tests right here in the UK, which could be suitable for use in developing countries. On Friday, the UK proudly stood with the WHO, the UN and 20 countries to work for global access to vaccines to end the pandemic, save lives and start the global economic recovery.
Covid-19: Research — House of Commons, 2020-04-29
Topic: Health
Elliot Colburn (Conservative, Centre-right): Carshalton and Wallington residents know that the development of a coronavirus vaccine is the greatest opportunity to save lives across the world. Will the Minister confirm that the UK is one of the largest global donors to the international Coalition for Epidemic Preparedness Innovations, which is at the fore- front of this global research?
Covid-19: Research — House of Commons, 2020-04-29
Topic: Health
Wendy Morton (Conservative, Centre-right): I can confirm that the UK Government have committed £250 million to the international Coalition for Epidemic Preparedness Innovations, or CEPI, to rapidly develop coronavirus vaccines. This is the largest contribution of any country to CEPI’s covid-19 efforts to date, and it is a major contribution to global efforts to accelerate vaccine discovery. In ensuring that a vaccine is available to all, including the world’s poorest countries, we are asking all Governments to contribute to this important international goal as a down payment against the wider funding needs of the covid-19 response.
Covid-19: Research — House of Commons, 2020-04-29
Topic: Health
Wendy Morton (Conservative, Centre-right): This is a very important point because of course a globally accessible vaccine, alongside effective tests and treatments, is needed to end this global pandemic and to start global economic recovery. This will need unprecedented global collaboration and resourcing to drive the speed and scale that are needed, and the UK is at the forefront of global efforts to meet this challenge. Now is the time for us to come together to develop and deliver vaccines, tests and treatments that are safe, effective, affordable and accessible to all.
Covid-19: Research — House of Commons, 2020-04-29
Topic: Health
Wendy Morton (Conservative, Centre-right): Of course, while we are focusing on covid-19, there is the broader issue of vaccines. The UK is already one of the biggest global donors. To date, we have pledged £744 million to support the international response to covid-19. We have also funded £40 million for the Wellcome and Mastercard therapeutics accelerator initiative, up to £23 million for the Foundation for Innovative New Diagnostics, and up to £5 million through the joint initiative on research for epidemic preparedness. Because we are faced with a global pandemic, we absolutely need an international response, and it is about making sure that vaccines reach all those who need them.
Covid-19: Overseas Territories — House of Commons, 2020-04-29
Topic: Defense
Robert Alexander Courts (Conservative, Centre-right): The Royal Navy is providing a pivotal role in providing medical assistance to British overseas territories. Will the Minister join me in recognising the dedication and skill of the servicemen and women of RFA Argus, which is providing that medical assistance to the Caribbean?
Covid-19: Overseas Territories — House of Commons, 2020-04-29
Topic: Defense
Wendy Morton (Conservative, Centre-right): I know that my hon. Friend takes a keen interest in defence matters, and I absolutely do agree that the Royal Navy continues to provide great service to the territories, particularly in the Caribbean. I, too, commend the servicemen and women of RFA Argus, who are providing vital support to the overseas territories. RFA Argus is boosting the resilience of the territories as they prepare for hurricane season. The FCO and DFID are providing further support to the territories to help deal with the impact of covid-19. In addition, an MOD security assistance team will be supporting local authorities in some of the territories as they respond to the coronavirus.
Developing Countries: Sanitation and Hygiene — House of Commons, 2020-04-29
Topic: Health
Wendy Morton (Conservative, Centre-right): Hand washing with soap and water, as we are all recognising, is the first line of defence against coronavirus transmission. The UK has world-leading commercial and scientific expertise on water, sanitation and hygiene. DFID has launched a £100 million scheme with British soap company Unilever to promote hygiene in developing countries, and has given a further £20 million to UNICEF to strengthen its coronavirus response in these areas. We are helping people around the world to defeat this virus.
Engagements — House of Commons, 2020-04-29
Topic: Health
James Roger Cartlidge (Conservative, Centre-right): Thank you, Mr Speaker. May I join you in sending heartiest congratulations to the Prime Minister and to Carrie on the birth of their son? It is wonderful news and I am sure that he will bring them great joy in these difficult times.On coronavirus, surely we should not underestimate the significance of getting to what we hope is the peak of the outbreak without the NHS being overwhelmed. To do that, we have had to take the difficult but unavoidable decision of putting elective surgery on hold for many people. What more can we do to free up the NHS so that our constituents with cancer and other serious non-covid conditions start being treated again as soon as possible, and in significant numbers?
Engagements — House of Commons, 2020-04-29
Topic: Health
Dominic Rennie Raab (Conservative, Centre-right): I have been asked to reply on behalf of my right hon. Friend the Prime Minister. As Members will have seen and as Mr Speaker has explained, the Prime Minister and his fiancée, Carrie Symonds, have announced the birth of a healthy baby boy this morning. Both mother and baby are doing well, and I am sure the whole House will want to join me in sending congratulations and our very best wishes to them The whole House will also want to join me in paying tribute to the 85 NHS workers and the 23 social care workers who have sadly died from coronavirus. My deepest sympathies are with their families and their friends at what is an incredibly difficult time, and we will continue to do whatever it takes to support them I am sure the whole House will also want to join me in wishing Captain Tom Moore, who has done so much in raising £29 million for NHS charities, a very happy 100th birthday tomorrow. His life of service for his country and his dedication to helping others is an inspiration to us all. As my hon. Friend the Member for South Suffolk (James Cartlidge) notes, it is because we have taken the right measures at the right time that we have flattened the peak of this virus and prevented the NHS from becoming overwhelmed—the two single most important elements of this strategy that we have delivered. That has meant that the NHS has had capacity to deal not just with covid-19 patients but other urgent treatments. My hon. Friend is also right to say that as we move forwards towards a second phase, we must plan to ensure that the NHS is able to deliver elective surgery and to treat patients with other conditions, which is exactly what we are planning to do.
Engagements — House of Commons, 2020-04-29
Topic: Health
Dominic Rennie Raab (Conservative, Centre-right): First, I welcome the various points of solidarity between our Front-Bench teams in relation not only to the new baby boy for the Prime Minister and Carrie Symonds but to the care workers and NHS workers who have lost their lives The right hon. and learned Gentleman is right that there is a challenge in deciphering the difference between the different figures because of the time lags in relation to the care home deaths. Equally, I know that on all sides we have wanted to deliver a clearer breakdown of and distinction between care home deaths and deaths in the NHS. I think that is progress The right hon. and learned Gentleman mentioned the target of 20,000. Of course, this is an unprecedented pandemic—a global pandemic—and in fairness we should not criticise either the chief medical officer or the deputy chief medical officer for trying to give some forecast in response to the questions that many in this Chamber and in the media are calling for. The reality is that we know a lot more about the virus, both domestically and internationally, than we did before I absolutely share with the right hon. and learned Gentleman our joint horror at the number of deaths—tragedies each and every one. Equally, I disagree with him: it is far too early to make international comparisons. If they are to be done, they should be done on a per capita basis. We are already seeing that deaths are measured in different ways, not just in the different settings in the UK but across Europe and around the world. This is of course, as I have said, a very delicate and dangerous moment in this pandemic, which is why, with the greatest respect, we need to wait until we have further evidence from the Scientific Advisory Group for Emergencies before moving towards a transitional phase or a second phase. It would be irresponsible right now to start setting out in detail what proposals we might come up with in advance of having that advice from SAGE.